Pricing medicines: theory and practice, challenges and opportunities.
about
Cell-based therapy technology classifications and translational challengesContribution of economic evaluation to decision making in early phases of product development: a methodological and empirical review.Foreign free riders and the high price of US medicinesEarly decision-analytic modeling - a case study on vascular closure devices.Reimbursement of licensed cell and gene therapies across the major European healthcare markets.The value of innovation under value-based pricing.Genetic redundancy strengthens the circadian clock leading to a narrow entrainment range.In a survey, marked inconsistency in how oncologists judged value of high-cost cancer drugs in relation to gains in survival.Rebuttal: are drugs too expensive in Canada?Melatonin prevents the development of the metabolic syndrome in male rats exposed to different light/dark regimens.Comparing Behavior and Clock Gene Expression between Caterpillars, Butterflies, and Moths.Pharmaceutical Price Schemes in Europe: Time for a 'Continental' One?Early evaluation and value-based pricing of regenerative medicine technologies.
P2860
Q26785346-B98392F6-580F-4CAD-9176-B8E774E41008Q33373185-EF18B0AC-3E90-4607-A42F-BDB8219E4C9AQ34089806-D6A1D4FB-ABF5-4744-8C22-03CC2B20CF71Q35823418-963AF6FE-6EE8-4404-A390-39E423EF1C91Q36714663-21A8FD6C-E7E7-4E6F-BD26-A91330F6C06AQ36783257-8EB2827B-F0F7-49AE-B934-9604DF589AFAQ36904260-301496DC-0B45-4D1B-9B57-551CEA930D84Q37289756-62260141-8D41-4B7A-8527-B475919FDDDBQ42984962-FBCF7C3D-3CAA-4E92-9338-4F52A8B2A38DQ44926781-9C02EA4E-6330-4D69-B0CF-12B88E08E904Q49581972-9695FB8F-869A-4229-BB7C-645CD3278184Q53195648-CC0ED730-EC6E-4950-A1B3-79F6165816BDQ54714604-34C19E72-F506-413B-86E8-34DEC8D9DFB6
P2860
Pricing medicines: theory and practice, challenges and opportunities.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Pricing medicines: theory and practice, challenges and opportunities.
@ast
Pricing medicines: theory and practice, challenges and opportunities.
@en
type
label
Pricing medicines: theory and practice, challenges and opportunities.
@ast
Pricing medicines: theory and practice, challenges and opportunities.
@en
prefLabel
Pricing medicines: theory and practice, challenges and opportunities.
@ast
Pricing medicines: theory and practice, challenges and opportunities.
@en
P2093
P356
P1476
Pricing medicines: theory and practice, challenges and opportunities.
@en
P2093
Josephine Mauskopf
Keiron Sparrowhawk
Nigel Gregson
P2860
P2888
P304
P356
10.1038/NRD1633
P577
2005-02-01T00:00:00Z